ClinicalTrials.Veeva

Menu

Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis

S

Shanghai Jiao Tong University School of Medicine

Status and phase

Not yet enrolling
Phase 2

Conditions

Pancreatectomy

Treatments

Other: Standard Medical Treatment
Drug: Indomethacin suppository

Study type

Interventional

Funder types

Other

Identifiers

NCT05722548
LYBWWG2023

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of rectal indomethacin in prevention of post-pancreatectomy acute pancreatitis.

Full description

The purpose of this study is to evaluate the efficacy of rectal indomethacin in prevention of post-pancreatectomy acute pancreatitis.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

*All patients planned to undergo pancreatectomy.

Exclusion criteria

  • asthma
  • allergic reactions to NSAIDs
  • CKD
  • internal hemorrhoids
  • anti-platelet medications

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

Group A
Experimental group
Description:
Patients will be administered 100mg of Indomethacin Suppository sigle dose at the time of induction of anesthesia with Standard Medical Treatment
Treatment:
Other: Standard Medical Treatment
Drug: Indomethacin suppository
Group B
Active Comparator group
Description:
Standard Medical Treatment
Treatment:
Other: Standard Medical Treatment

Trial contacts and locations

0

Loading...

Central trial contact

Yingbin Liu, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems